REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot162310.32687/1561-5936-2023-27-2-113-117Original ArticleAnalysis of the efficiency of colorectal cancer diagnostics in patients with malignant neoplasms detected for the first timeNaygovzinaNelli B.nnb@koziz.ru, https://orcid.org/0000-0001-9479-9084PatrushevMikhail A.002A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia15122023211311710102025Copyright © 2023,2023This article presents an analysis of the routing of patients in the diagnosis of malignant neoplasms of colorectal localization based on the data of primary medical documentation at the place of diagnosis and retrospectively in outpatient facilities during preventive examinations and medical examinations.malignant neoplasmsdiagnosticsscreeningProgram of state guarantees of free provision of medical care to citizensmorbiditymortalityзлокачественные новообразованиядиагностикаскринингПрограмма государственных гарантий бесплатного оказания гражданам медицинской помощизаболеваемостьсмертностьпрофилактические осмотрыдиспансеризация[Kaprin A. D. et al. (eds.) Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow; 2020. 252 p.; 2. Nesterov P. V., Ukharskiy A. V., Kislov N. V. Regional clinical and economic model of colorectal cancer screening. Research and Practical Medicine Journal. 2020;7(3):146—159. doi: 10.17709/2409-2231-2020-7-3-15 (In Russ.); 3. Jahn B., Sroczynski G., Bundo M. et al. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria. BMC Gastroenterol. 2019;19:209. doi: 10.1186/s12876-019-1121-y; 4. Worthington J., Lew J. B., Feletto E. et al. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment. PLoS One. 2020;15(2):e0227899. doi: 10.1371/journal.pone.0227899]